Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SILQ (Malaysia) specializes in advanced biomaterial-based surface modification technologies, particularly for medical devices. Their platform is designed to impart properties such as microbial resistance, antibiofouling, and enhanced lubricity to surfaces, with applications in implantable devices and industrial components. Their leading product is the Silq ClearTract® Foley Catheter, which utilizes their FDA-cleared surface treatment technology aimed at reducing catheter-related complications[1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SILQ (MALAYSIA) SDN. BHD..